Literature DB >> 2838962

Murray Valley encephalitis virus field strains from Australia and Papua New Guinea: studies on the sequence of the major envelope protein gene and virulence for mice.

M Lobigs1, I D Marshall, R C Weir, L Dalgarno.   

Abstract

We have compared the nucleotide sequence of the gene encoding the major envelope (E) protein of a number of Murray Valley encephalitis virus (MVE) isolates from Australia and Papua New Guinea (PNG). The isolates, from widely separated geographic regions, were from four fatal human cases, a heron, and six mosquito pools and covered a period of 25 years. The sequences of the Australian strains were notable for their similarity, showing not more than 1.7% nucleotide sequence divergence in pairwise comparisons. There was 6.8% divergence in the E gene between the two available strains from PNG, and 9-10% divergence between each of the PNG strains and the Australian prototype. These data are consistent with previous conclusions based on HaeIII restriction digest analysis of cDNA to virion RNA (M. Lobigs, I. D. Marshall, R. C. Weir, and L. Dalgarno, 1986, Aust. J. Exp. Biol. Med. Sci. 64, 571-585). We conclude that a single MVE genetic type exists in Australia. Separate foci of MVE evolution appear to exist in PNG, generating greater strain variation. For all MVE isolates the deduced length of the E protein was 501 amino acids. The E protein differed at no more than three positions between any two Australian strains. The PNG strains differed from the Australian strains at 6-11 residues depending on the virus pair. Differences in amino acid sequence did not occur at a position corresponding to a previously demonstrated neutralization determinant in yellow fever virus (M. Lobigs, L. Dalgarno, J. J. Schlesinger, and R. C. Weir, 1987, Virology 161, 474-478). Thus selection for neutralization resistance may not be a major evolutionary pressure in the field situation. In comparisons between the E protein amino acid sequence of the prototype strain and those of a number of other MVE strains, 7 out of 14 differences were at residues seen at the corresponding position for Japanese encephalitis virus (JE), consistent with the close serological relationship of MVE and JE. Five Australian MVE strains and two from PNG were tested for virulence by comparing LD50 values after intraperitoneal and intracranial inoculation of 21-day-old mice; all strains were virulent by this test.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838962     DOI: 10.1016/0042-6822(88)90678-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

Review 1.  Molecular epidemiology and evolution of mosquito-borne flaviviruses and alphaviruses enzootic in Australia.

Authors:  J S Mackenzie; M Poidinger; M D Lindsay; R A Hall; L M Sammels
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

Review 2.  Flavivirus Envelope Protein Glycosylation: Impacts on Viral Infection and Pathogenesis.

Authors:  Derek L Carbaugh; Helen M Lazear
Journal:  J Virol       Date:  2020-05-18       Impact factor: 5.103

3.  Genetic and biological differentiation of dengue 3 isolates obtained from clinical cases in Java, Indonesia, 1976-1978.

Authors:  E Lee; D J Gubler; R C Weir; L Dalgarno
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Nucleotide sequence of the envelope protein gene of the tick-borne flavivirus, Kumlinge A52.

Authors:  J E Whitby; A D Jennings; A D Barrett
Journal:  Virus Genes       Date:  1993-06       Impact factor: 2.332

Review 5.  Arboviruses causing human disease in the Australasian zoogeographic region.

Authors:  J S Mackenzie; M D Lindsay; R J Coelen; A K Broom; R A Hall; D W Smith
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry.

Authors:  E Lee; M Lobigs
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  Origin and evolution of Japanese encephalitis virus in southeast Asia.

Authors:  Tom Solomon; Haolin Ni; David W C Beasley; Miquel Ekkelenkamp; Mary Jane Cardosa; Alan D T Barrett
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

8.  An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody.

Authors:  Nikolai Petrovsky; Maximilian Larena; Venkatraman Siddharthan; Natalie A Prow; Roy A Hall; Mario Lobigs; John Morrey
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

9.  Genetic and phenotypic differences between isolates of Murray Valley encephalitis virus in Western Australia, 1972-2003.

Authors:  Cheryl A Johansen; Veronica Susai; Roy A Hall; John S Mackenzie; David C Clark; Fiona J May; Stéphane Hemmerter; David W Smith; Annette K Broom
Journal:  Virus Genes       Date:  2007-03-29       Impact factor: 2.332

10.  A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.

Authors:  Wen Jun Liu; Xiang Ju Wang; David C Clark; Mario Lobigs; Roy A Hall; Alexander A Khromykh
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.